Aid in the diagnosis of blastomycosis
Monitor the response to therapy and to determine when treatment can be modified or stopped.
Monitor Blastomyces antigen levels to help determine relapse of disease.
Red Top Tube (RTT)
Sodium-heparin OR Lithium-heparin Green Top Tube (GTT)
OR
Sodium citrate tube (BTT)
Serum: Collect serum specimens in serum separator or red top tube. Allow blood to clot for 30 minutes, then centrifuge. Pipette serum into a plastic screw cap vial.
Plasma: Collect plasma specimens in an EDTA, heparin or sodium citrate tube. Centrifuge for 15 minutes and pipette plasma into a plastic screw cap vial.
Ship to arrive Monday through Saturday using a next day delivery service.
Samples may be shipped on dry ice, frozen ice packs, or ambient.
It is possible that specimens positive for Candida tropicalis, Coccidioides immitis, Coccidioides posadasii, Histoplasma capsulatum, Histoplasma duboisii, Paracoccidioides brasiliensis, Talaromyces marneffei and Aspergillus nidulans may cross-react with the Blastomyces Antigen EIA and test positive.
A variety of interfering substances, as follows, were investigated for each specimen type and none affected the Blastomyces Antigen EIA sensitivity or specificity.
Quantitative sandwich enzyme immunoassay (EIA)
Serum is pre-treated to improve accuracy
The MVista® Blastomyces Antigen Quantitative EIA can detect and quantify the amount of Blastomyces antigen in patient samples.
During validation testing, the sensitivity was found to be 95.00% and specificity 100% with an assay cutoff of 0.31 ng/mL.
Negative results do not exclude blastomycosis. Testing of both urine and serum offers the highest sensitivity. Failure of the antigen to rise does not exclude relapse.
Positive samples may require confirmation which could extend TAT.
None Detected: <0.31 ng/mLPositive: ≥0.31 ng/mL – 20.00 ng/mLPositive Above the Limit of QuantificationsResults greater than 20.00 ng/mL fall outside the linear range of the assay. These results are positive, but not accurately quantifiable.
Results should be correlated with clinical presentation and history